Abiomed traded at $249.08 this Tuesday June 28th, decreasing $5.70 or 2.24 percent since the previous trading session. Looking back, over the last four weeks, Abiomed lost 5.54 percent. Over the last 12 months, its price fell by 20.49 percent. Looking ahead, we forecast Abiomed to be priced at 248.45 by the end of this quarter and at 228.94 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
249.08
Daily Change
-2.24%
Yearly
-20.49%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Terumo 4,093.00 -18.00 -0.44% -9.08%
Abiomed 249.08 -5.70 -2.24% -20.49%
Abbott 106.97 -2.11 -1.93% -8.74%
AtriCure 39.66 -1.05 -2.58% -49.99%
Avanos Medical Inc 26.69 -0.07 -0.26% -28.04%
Baxter International 65.25 -1.46 -2.19% -20.29%
Boston Scientific 37.50 -0.32 -0.85% -13.25%
Cooper Companies 314.08 -7.99 -2.48% -20.91%
Cardiovascular Systems 14.62 -0.19 -1.28% -65.87%
Dexcom 74.70 -1.90 -2.48% -82.50%
Edwards Lifesciences 94.73 -2.08 -2.15% -8.55%
Getinge 236.20 0 0% -28.23%
Globus Medical 57.55 -1.16 -1.98% -24.63%
Hologic 69.78 -1.68 -2.35% 1.35%
Integra LifeSciences 54.46 -0.54 -0.98% -20.52%
Inogen 24.42 -1.21 -4.72% -62.70%
Invacare 1.49 -0.05 -3.25% -81.35%
J&J 176.94 -5.18 -2.84% 7.87%
Masimo 137.07 -2.73 -1.95% -44.48%
Medtronic 89.20 -1.27 -1.40% -28.38%
Merit Medical Systems 53.77 -1.11 -2.02% -16.66%
NuVasive 49.62 -1.26 -2.48% -27.04%
Insulet 226.21 -2.00 -0.88% -20.19%
Sientra 0.88 -0.07 -7.05% -87.90%
Stryker 197.80 -5.33 -2.62% -24.05%
Teleflex 253.26 -6.30 -2.43% -38.02%
Tandem Diabetes Care 60.34 -0.65 -1.07% -39.77%
Zimmer Biomet Holdings Inc 106.48 -2.03 -1.87% -33.94%

Indexes Price Day Year
USND 11182 -343.01 -2.98% -23.04%
US2000 1739 -32.90 -1.86% -24.69%
US500 3825 -78.56 -2.01% -10.99%

Abiomed
ABIOMED, Inc. is a provider of medical devices, which provides circulatory support and oxygenation. The Company develops, manufactures and markets its products, which are designed to improve blood flow and/or performing the pumping function of the heart. Its products are used in the cardiac catheterization lab (cath lab), by interventional cardiologists and in the heart surgery suite by cardiac surgeons for patients who are in need of hemodynamic support prophylactically or emergently before, during or after angioplasty or heart surgery procedures. Its operating segment includes the research, development and sale of medical devices to assist or replace the pumping function of the failing heart. Its existing products include Impella 2.5, Impella CP, Impella 5.0 and Impella LD. The Impella 2.5 device is a percutaneous micro heart pump with an integrated motor and sensors. The Impella CP device provides blood flow of approximately one liter more per minute than the Impella 2.5 device.